FI923869A0 - Farmaceutiska aemnen. - Google Patents

Farmaceutiska aemnen.

Info

Publication number
FI923869A0
FI923869A0 FI923869A FI923869A FI923869A0 FI 923869 A0 FI923869 A0 FI 923869A0 FI 923869 A FI923869 A FI 923869A FI 923869 A FI923869 A FI 923869A FI 923869 A0 FI923869 A0 FI 923869A0
Authority
FI
Finland
Prior art keywords
methyl
pharmaceutical
aemnen
physical
trifluorobutylcarbamoyl
Prior art date
Application number
FI923869A
Other languages
English (en)
Other versions
FI923869A (fi
FI102372B1 (fi
FI102372B (fi
Inventor
Murray Watson Cuthbert
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of FI923869A0 publication Critical patent/FI923869A0/fi
Publication of FI923869A publication Critical patent/FI923869A/fi
Application granted granted Critical
Publication of FI102372B1 publication Critical patent/FI102372B1/fi
Publication of FI102372B publication Critical patent/FI102372B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI923869A 1991-09-05 1992-08-28 Menetelmä karbamyylijohdannaisen kiteisen muodon valmistamiseksi FI102372B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9119001 1991-09-05
GB919119001A GB9119001D0 (en) 1991-09-05 1991-09-05 Pharmaceutical agents

Publications (4)

Publication Number Publication Date
FI923869A0 true FI923869A0 (fi) 1992-08-28
FI923869A FI923869A (fi) 1993-03-06
FI102372B1 FI102372B1 (fi) 1998-11-30
FI102372B FI102372B (fi) 1998-11-30

Family

ID=10700953

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923869A FI102372B (fi) 1991-09-05 1992-08-28 Menetelmä karbamyylijohdannaisen kiteisen muodon valmistamiseksi

Country Status (21)

Country Link
US (2) US5352694A (fi)
EP (1) EP0531078B1 (fi)
JP (1) JP2914414B2 (fi)
KR (1) KR100254710B1 (fi)
AT (1) ATE138910T1 (fi)
AU (1) AU646587B2 (fi)
CA (1) CA2076722A1 (fi)
CZ (1) CZ281999B6 (fi)
DE (1) DE69211258T2 (fi)
DK (1) DK0531078T3 (fi)
FI (1) FI102372B (fi)
GB (2) GB9119001D0 (fi)
HK (1) HK18297A (fi)
HU (2) HU213410B (fi)
IL (1) IL102856A (fi)
NO (1) NO178370C (fi)
NZ (1) NZ244016A (fi)
RU (1) RU2095348C1 (fi)
SK (1) SK267092A3 (fi)
TW (1) TW302359B (fi)
ZA (1) ZA926374B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958780A (en) 1997-06-30 1999-09-28 Boston Advanced Technologies, Inc. Method for marking and identifying liquids
US6149914A (en) * 1999-07-12 2000-11-21 Patel; Jitendra Rambhai Asthma treatment
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
EP1997491B1 (en) 2004-07-14 2010-09-22 Inflammation Research Center Company Ltd. Method for inhibiting tumor metastasis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524152A (en) * 1982-12-30 1985-06-18 Pennwalt Corporation 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure
GB8623429D0 (en) * 1985-10-17 1986-11-05 Ici America Inc Carboximide derivatives
MY103259A (en) * 1987-04-15 1993-05-29 Ici America Inc Aliphatic carboxamides
GB8906032D0 (en) * 1988-04-14 1989-04-26 Ici America Inc Hetera-aliphatic carboxamides
GB8927981D0 (en) * 1989-12-11 1990-02-14 Ici Plc Carbamoyl derivative
GB9026425D0 (en) * 1990-12-05 1991-01-23 Ici Plc Process
GB9026427D0 (en) * 1990-12-05 1991-01-23 Ici Plc Chemical process
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
NZ244016A (en) 1995-01-27
EP0531078A1 (en) 1993-03-10
TW302359B (fi) 1997-04-11
CZ267092A3 (en) 1993-03-17
JP2914414B2 (ja) 1999-06-28
ZA926374B (en) 1993-03-05
FI923869A (fi) 1993-03-06
IL102856A0 (en) 1993-01-31
SK279657B6 (sk) 1999-02-11
DE69211258T2 (de) 1996-10-02
NO923467D0 (no) 1992-09-04
NO178370B (no) 1995-12-04
GB9216774D0 (en) 1992-09-23
AU2101292A (en) 1993-03-11
EP0531078B1 (en) 1996-06-05
KR930005976A (ko) 1993-04-20
HUT69696A (en) 1995-09-28
HK18297A (en) 1997-02-13
NO923467L (no) 1993-03-08
RU2095348C1 (ru) 1997-11-10
CA2076722A1 (en) 1993-03-06
HU9202660D0 (en) 1992-10-28
CZ281999B6 (cs) 1997-04-16
SK267092A3 (en) 1999-02-11
IL102856A (en) 1996-12-05
NO178370C (no) 1996-03-13
US5352694A (en) 1994-10-04
ATE138910T1 (de) 1996-06-15
GB9119001D0 (en) 1991-10-23
AU646587B2 (en) 1994-02-24
HU210879A9 (en) 1995-09-28
FI102372B1 (fi) 1998-11-30
HU213410B (en) 1997-06-30
KR100254710B1 (ko) 2000-05-01
FI102372B (fi) 1998-11-30
DE69211258D1 (de) 1996-07-11
DK0531078T3 (da) 1996-10-14
US5466826A (en) 1995-11-14
JPH05194385A (ja) 1993-08-03

Similar Documents

Publication Publication Date Title
AU683442B2 (en) Aminoacid derivates, medicaments containing these compounds and process for preparing the same
LU90843I2 (fr) Starlix-nateglinide et ses d-riv-s pharmaceutiquement acceptables
ES2100136T1 (es) Omeprazol magnesico.
CA2208839A1 (en) Quinuclidine derivatives and medicinal composition thereof
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
NZ242104A (en) Amides of aminoethylsubstituted benzothiazole, -thiazine, -oxazole and -oxazine derivatives; pharmaceutical compositions thereof
BR9304910A (pt) Composto, processo para a sua preparação, medicamento, processo para a sua preparação e aplicação do dito composto
FI923869A (fi) Farmaceutiska aemnen
NO910904D0 (no) Fremgangsmaate for fremstilling av en substituert aminforbindelse.
HUT55033A (en) Process for producing aminooligohydroxy derivatives and pharmaceutical compositions comprising same
JPS5620572A (en) 4-tert-butylbenzamide derivative and antimicrobial containing the same
EP0301401A3 (en) Leukotriene antagonists, process for their preparation, their use in the treatment of illnesses, as well as precursors
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ZENECA LIMITED

MA Patent expired